Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma.
Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, Zhao P, Tretiakova MS, Korpi-Hyovalti E, Burgess JR, Soo KC, Cheah WK, Cao B, Resau J, Morreau H, Teh BT.
Tan MH, et al. Among authors: zhao p.
Clin Cancer Res. 2004 Oct 1;10(19):6629-37. doi: 10.1158/1078-0432.CCR-04-0493.
Clin Cancer Res. 2004.
PMID: 15475453